跳至主要内容
临床试验/NCT06970314
NCT06970314尚未招募不适用

Comparative Study of Working With the LoKomat® Exoskeleton VS C-Mill® Treadmill for Gait Recovery in Rehabilitation and Improvement of Quality of Life in Adult Stroke Patients. Randomised Clinical Trial.

Universidad Católica de Ávila2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
2
主要终点
quality of life scale

研究概览

简要总结

The use of robotic technology for the treatment of gait in neurological pathologies has provided different results in scientific evidence. In patients with some types of acquired brain damage, such as stroke, the use of Lokomat® therapy can bring improvements in aspects such as gait speed and balance, among other parameters and report greater functional recovery in subacute patients with greater deterioration. Similarly, the use of another technological element such as the C-Mill® reports improvements in various aspects of ambulation and balance in gait treatments for stroke patients. Likewise, the impact on the person's recovery is not only beneficial for gait rehabilitation, but also improves the perception of well-being, which can be positive in the process of readaptation to daily life.

The effect of both treatments for gait rehabilitation in adults with stroke and their impact on quality of life in the neurorehabilitation clinic will be studied.

adults with stroke and their impact on quality of life at the Lescer neurorehabilitation clinic Lescer, Madrid (Spain).Participants will be assessed at baseline, 4 weeks, 8 weeks and 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of stroke (haemorrhagic and/or ischaemic) by a specialist physician. specialist.
  • Subjects who are cognitively capable and who sign the informed consent form.

排除标准

  • Severe cognitive impairment (Mini-Mental State Examination < 24.), or impairment that prevents correct understanding of the correct understanding of the messages and explanatory orders of the treatment and its conditions.
  • conditions.
  • Diagnosis of concomitant neurological diseases and craniocerebral trauma. cranioencephalic trauma.
  • Other diseases that interfere with the gait process (e.g. disabling arthritis or arthrosis, other neurological diseases, other neurological diseases).
  • disabling arthritis or osteoarthritis, other concomitant neurological diseases, etc.).
  • Contraindications of the robotic tools themselves.

结局指标

主要结局

quality of life scale

时间窗: 12 weeks

QoL39 scale. 0 minimum - 100 maximum (higher scores mean a better outcome).

次要结局

  • Spasticity index(12 weeks.)

研究者

发起方
Universidad Católica de Ávila
申办方类型
Other
责任方
Principal Investigator
主要研究者

JORGE VELAZQUEZ SAORNIL

Principal Investigator

Universidad Católica de Ávila

研究点 (2)

Loading locations...

相似试验

Comparative Study of LoKomat® Exoskeleton VS C-Mill®... | 临床试验